ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 939 filers reported holding ASTRAZENECA PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,632 | -5.4% | 600 | 0.0% | 0.00% | – |
| Q2 2023 | $42,942 | +102142.9% | 600 | 0.0% | 0.00% | – |
| Q1 2023 | $42 | -98.4% | 600 | -98.4% | 0.00% | -100.0% |
| Q4 2022 | $2,617 | -92.1% | 38,600 | +6333.3% | 0.02% | – |
| Q3 2022 | $33,000 | -97.1% | 600 | -96.6% | 0.00% | -100.0% |
| Q2 2022 | $1,154,000 | -0.3% | 17,462 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $1,158,000 | +62.4% | 17,462 | +47.1% | 0.01% | +100.0% |
| Q3 2021 | $713,000 | +180.7% | 11,873 | +147.4% | 0.00% | +100.0% |
| Q2 2020 | $254,000 | +18.7% | 4,800 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $214,000 | -27.2% | 4,800 | -18.6% | 0.00% | -33.3% |
| Q4 2019 | $294,000 | -19.5% | 5,900 | -28.0% | 0.00% | 0.0% |
| Q3 2019 | $365,000 | +8.0% | 8,200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $338,000 | +1.8% | 8,200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $332,000 | +6.8% | 8,200 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $311,000 | -8.5% | 8,200 | -4.7% | 0.00% | 0.0% |
| Q3 2018 | $340,000 | – | 8,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |